Insider Transactions in Q2 2024 at Beam Therapeutics Inc. (BEAM)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
60,000
-5.67%
|
$1,440,000
$24.5 P/Share
|
|
Apr 26
2024
|
Terry Ann Burrell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+13.14%
|
-
|
|
Apr 02
2024
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,530
-19.09%
|
$495,900
$30.54 P/Share
|
|
Apr 01
2024
|
Christine Bellon Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,401
-3.15%
|
$108,832
$32.12 P/Share
|
|
Apr 01
2024
|
Amy Simon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,157
-7.63%
|
$229,024
$32.13 P/Share
|
|
Apr 01
2024
|
John M. Evans CEO |
SELL
Open market or private sale
|
Direct |
18,102
-1.68%
|
$579,264
$32.13 P/Share
|
|
Apr 01
2024
|
Terry Ann Burrell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,446
-7.21%
|
$174,272
$32.12 P/Share
|
|
Apr 01
2024
|
Giuseppe Ciaramella President |
SELL
Open market or private sale
|
Direct |
4,534
-2.6%
|
$145,088
$32.12 P/Share
|